Examination of tumors treated with VG161 compared to equivalent tumors exposed to VG160 provides compelling evidence that VG161 induced a potent systemic anti-tumor immune response in vivo, revealing increased infiltration of NK cells, macrophages, and both CD4+ and CD8+ tumor-specific T cells. Here, CD8A is linked to neoplasm.